Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Streptococcus dentisani's Antimicrobial Peptides: New Strategy Against Oral Diseases of Microbial Origin.

Project description

Probiotics for groundbreaking oral hygiene

Oral health prevents caries and periodontal diseases and tooth loss. It’s also important for our overall health and well-being. However, billions of people worldwide do not have access to affordable oral care, which the World Health Organization says is a priority. Effective prevention based on balanced treatment of oral microbiota could be an answer. In this direction, the EU-funded SMILES project proposes a cost-effective preventive solution through the development of cocktails with biomedical application that will be based on specific characteristics of the antimicrobial peptides produced by Streptococcus dentisani, a probiotic bacterium. This will enable new widely accessible products to prevent diseases resulting from microbial dysbiosis.

Objective

Billions of people suffer from oral diseases world-wide while oral health treatments are not affordable for everyone. Goal 3 of the United Nations Sustainable Development challenge/priority programs, to be reached by 2030, is to promote “access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines [..] for all”. The WHO points therefore towards cost-effective oral disease prevention as a key strategy to reach a universal health care access. The main scientific objective of SMILES is identifying, characterizing, and harnessing antimicrobial peptides (AMPs) produced by Streptococcus dentisani and select cocktails with biomedical application in the treatment of caries and periodontitis. S. dentisani is a probiotic bacterium which produces AMPs, and which is naturally found in oral disease-free individuals maintaining the balance for a healthy oral microbiota. Caries and periodontitis are two oral diseases resulting from microbial dysbiosis. These cocktails could be incorporated in the future as additives in conventional oral hygiene products (ex. toothpaste), as oral disease preventive agents accessible for the public independently of their monetary resources. Dr. Revilla-Guarinos has expertise in antimicrobial resistance and will lead SMILES. The research and training at the academic host institution will be complemented with an intersectoral secondment in DENTAID (an oral health care products leading company), international networking & collaborations, specialized training courses & complementary skills workshops. Dissemination & exploitation activities, as well as communication & outreach events will promote the action and its results. The overarching ambition of this action is training and preparing Dr. Revilla-Guarinos for her to start her own group in academia or, alternatively, to develop a new path by changing to a career in industry, working at the forefront of Applied Microbiology in Europe.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2020

See all projects funded under this call

Coordinator

FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA
Net EU contribution
€ 160 932,48
Address
CALLE MICER MASCO 31
46010 Valencia
Spain
Region
Este Comunitat Valenciana Valencia/València
Activity type
Research Organisations
Links
Total cost
€ 160 932,48